Seeing the invisible: Reorienting cardiovascular risk prediction across the disease trajectory
Open Access
- 21 October 2026
- journal article
- perspective
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1005263
Abstract
Current risk equations miss many cardiovascular events in people classified as low risk. Prediction is simultaneously advancing on two axes: broadening predictors toward molecular omics, and expanding outcomes toward earlier subclinical atherosclerosis and later heart failure.Keywords
Funding Information
- National Major Science and Technology Projects of China (2024ZD0527406)
- National Natural Science Foundation of China (82373662)
- Natural Science Foundation of Beijing Municipality (IS24047)
This publication has 13 references indexed in Scilit:
- Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk modelEuropean Heart Journal, 2026
- The burden of cardiovascular events according to cardiovascular risk profile in adults from high-income, middle-income, and low-income countries (PURE): a cohort studyThe Lancet Global Health, 2025
- Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selectionThe Lancet Global Health, 2024
- Personalized Intervention Based on Early Detection of AtherosclerosisJACC, 2024
- AI-enabled electrocardiography alert intervention and all-cause mortality: a pragmatic randomized clinical trialNature Medicine, 2024
- Large-scale plasma proteomics in the UK Biobank modestly improves prediction of major cardiovascular events in a population without previous cardiovascular diseaseEuropean Journal of Preventive Cardiology, 2024
- Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular EventsJAMA, 2023
- Proteomics and lipidomics in atherosclerotic cardiovascular disease risk predictionEuropean Heart Journal, 2023
- A dynamic risk-based early warning monitoring system for population-based management of cardiovascular diseaseFundamental Research, 2021
- Improved cardiovascular risk prediction using targeted plasma proteomics in primary preventionEuropean Heart Journal, 2020